Healthline lands Drugs.com ad deal

Share this article:

Healthline Networks has secured a deal with Drugs.com giving it exclusive rights to sell consumer ads on the site, which boasts 8.8 million unique visitors per month.

The agreement boosts Healthline's reach to nearly 55 million monthly uniques, said the San Francisco firm, or about half the monthly health information audience, per comScore stats.

“We wanted a partner that could help marketers take advantage of our critical position in the treatment consideration process,” said Drugs.com CEO Philip Thornton. “Healthline not only gives us a roster of strategic sellers with deep DTC experience but original, engaging content and visual learning solutions that can help marketers reach consumers and healthcare providers at a critical point of decision.”

Healthline's backers include Kaiser Permanente,  Aetna, Reed Elsevier and GE/NBC Peacock Fund. It offers search, advertising and content services through partnerships with 50-plus sites including web publishers, portals, search engines, employers and health plans.
Share this article:
close

Next Article in Agency Gallery

Email Newsletters

More in Agency Gallery

Private View: Creating Compelling Experiences

Private View: Creating Compelling Experiences

In today's multi-channel environment, game-changing ideas blend creativity and sensory ideation to create a meaningful customer experience

Putting consumers at the center of your universe

Putting consumers at the center of your universe

The question should be: How do you simplify and identify the moments that mean the most to customers?

Did "pay-to-play" confab help Zohydro approval?

Did "pay-to-play" confab help Zohydro approval?

US senators Joe Manchin (D-WV) and David Vitter (R-LA) are asking whether a "pay-to-play" meeting between drug industry executives and FDA officials influenced the agency's approval of Zohydro